SK bioscience Co.,Ltd. (KRX:302440)
South Korea flag South Korea · Delayed Price · Currency is KRW
42,850
-150 (-0.35%)
At close: May 28, 2025, 3:30 PM KST

SK bioscience Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-47,629-53,88122,318122,452355,139
Depreciation & Amortization
61,26749,22534,76527,23618,775
Loss (Gain) From Sale of Assets
-14,152-14,25968.06434.6-23.62
Asset Writedown & Restructuring Costs
1.411.411,154--
Loss (Gain) From Sale of Investments
-22,103-24,162-13,777-36,875-892.14
Provision & Write-off of Bad Debts
29.93-81.7-29.33-21.08-9.4
Other Operating Activities
-138,581-124,9253,240-29,807119,603
Change in Accounts Receivable
-19,660-2,47226,674-4,770-7,595
Change in Inventory
99,80079,41052,888-96,230-70,337
Change in Accounts Payable
6,373-1,243-7,683-52,75946,536
Change in Other Net Operating Assets
40,945-35,632-90,271-54,62075,397
Operating Cash Flow
-33,708-128,02029,346-124,958536,594
Capital Expenditures
-131,839-164,413-43,461-72,993-42,907
Sale of Property, Plant & Equipment
16,52816,5290.5434.5747.08
Cash Acquisitions
-216,758-216,758---
Sale (Purchase) of Intangibles
-14,539-7,811-6,834-3,497-1,562
Investment in Securities
260,087423,3297,377352,052-1,384,617
Other Investing Activities
4,1792,688-2,361-2,951-235.56
Investing Cash Flow
-82,34253,564-45,279272,647-1,421,940
Short-Term Debt Issued
--1,00048,74211,324
Long-Term Debt Issued
-192,057---
Total Debt Issued
112,057192,0571,00048,74211,324
Short-Term Debt Repaid
---45,425-16,196-50
Long-Term Debt Repaid
--10,791-51,039-55,031-35,521
Total Debt Repaid
-9,637-10,791-96,464-71,227-35,571
Net Debt Issued (Repaid)
102,420181,266-95,464-22,485-24,247
Issuance of Common Stock
75,68075,680397.62,618983,256
Other Financing Activities
-4,467-4,4675,484--628.09
Financing Cash Flow
173,633252,479-89,583-19,867958,380
Foreign Exchange Rate Adjustments
13,2617,6537,253-561.8722.25
Net Cash Flow
70,844185,676-98,262127,25973,056
Free Cash Flow
-165,547-292,433-14,114-197,951493,686
Free Cash Flow Margin
-41.40%-109.30%-3.82%-43.34%53.14%
Free Cash Flow Per Share
-2133.85-3787.93-183.27-2570.086686.61
Cash Interest Paid
5,7713,5671,3972,6813,407
Cash Income Tax Paid
19,2784,65825,639104,2108,987
Levered Free Cash Flow
-184,617-345,40813,402-203,405-
Unlevered Free Cash Flow
-180,966-343,10514,276-201,867-
Change in Net Working Capital
17,445133,586-37,298224,497-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.